# Health-related Quality of Life in Patients on Anticoagulants

> **NCT03134911** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 535 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** DOAC or VKA
- **DRUG:** VKA

## Key facts

- **NCT ID:** NCT03134911
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-24
- **Primary completion:** 2018-01-31
- **Final completion:** 2018-01-31
- **Target enrollment:** 535 (ACTUAL)
- **Last updated:** 2019-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03134911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03134911, "Health-related Quality of Life in Patients on Anticoagulants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03134911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*